MetLife Investment Management, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$55,000
-70.6%
23,421
-64.4%
0.00%
-50.0%
Q4 2017$187,000–65,750–0.00%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders